0 XP   0   0   0

Cocrystal Pharma Inc










Financial Health of Cocrystal Pharma Inc




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Cocrystal Pharma Inc
Buy, Hold or Sell?

Should you buy, hold or sell Cocrystal Pharma Inc?

I guess you are interested in Cocrystal Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Cocrystal Pharma Inc

Let's start. I'm going to help you getting a better view of Cocrystal Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Cocrystal Pharma Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Cocrystal Pharma Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Cocrystal Pharma Inc. The closing price on 2022-12-02 was $2.74 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Cocrystal Pharma Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Cocrystal Pharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cocrystal Pharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cocrystal Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-17.0%+17.0%
TTM-17.0%YOY-343.9%+326.9%
TTM-17.0%5Y-794.9%+777.9%
5Y-794.9%10Y-4,542.7%+3,747.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM-17.0%-281.7%+264.7%
YOY-343.9%-344.8%+0.9%
5Y-794.9%-450.1%-344.8%
10Y-4,542.7%-541.0%-4,001.7%
1.1.2. Return on Assets

Shows how efficient Cocrystal Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • -46.6% Return on Assets means that Cocrystal Pharma Inc generated $-0.47 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cocrystal Pharma Inc:

  • The MRQ is -46.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.6%TTM-14.2%-32.4%
TTM-14.2%YOY-4.3%-9.9%
TTM-14.2%5Y-19.5%+5.3%
5Y-19.5%10Y-20.6%+1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.6%-9.9%-36.7%
TTM-14.2%-8.9%-5.3%
YOY-4.3%-9.3%+5.0%
5Y-19.5%-11.7%-7.8%
10Y-20.6%-12.7%-7.9%
1.1.3. Return on Equity

Shows how efficient Cocrystal Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • -49.5% Return on Equity means Cocrystal Pharma Inc generated $-0.49 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cocrystal Pharma Inc:

  • The MRQ is -49.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-49.5%TTM-15.0%-34.4%
TTM-15.0%YOY-4.5%-10.5%
TTM-15.0%5Y-20.9%+5.8%
5Y-20.9%10Y-37.3%+16.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-49.5%-12.0%-37.5%
TTM-15.0%-11.5%-3.5%
YOY-4.5%-10.8%+6.3%
5Y-20.9%-14.2%-6.7%
10Y-37.3%-15.2%-22.1%

1.2. Operating Efficiency of Cocrystal Pharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cocrystal Pharma Inc is operating .

  • Measures how much profit Cocrystal Pharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cocrystal Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-17.0%+17.0%
TTM-17.0%YOY-343.7%+326.7%
TTM-17.0%5Y-806.5%+789.5%
5Y-806.5%10Y-5,249.0%+4,442.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM-17.0%-271.0%+254.0%
YOY-343.7%-325.9%-17.8%
5Y-806.5%-454.0%-352.5%
10Y-5,249.0%-537.1%-4,711.9%
1.2.2. Operating Ratio

Measures how efficient Cocrystal Pharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.171-0.171
TTM0.171YOY3.946-3.775
TTM0.1715Y2.903-2.733
5Y2.90310Y73.968-71.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM0.1713.504-3.333
YOY3.9463.604+0.342
5Y2.9035.132-2.229
10Y73.9686.371+67.597

1.3. Liquidity of Cocrystal Pharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cocrystal Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 18.34 means the company has $18.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 18.342. The company is very able to pay all its short-term debts. +2
  • The TTM is 35.786. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ18.342TTM35.786-17.444
TTM35.786YOY22.265+13.521
TTM35.7865Y14.076+21.710
5Y14.07610Y7.707+6.369
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.3425.117+13.225
TTM35.7865.755+30.031
YOY22.2655.854+16.411
5Y14.0766.511+7.565
10Y7.7076.222+1.485
1.3.2. Quick Ratio

Measures if Cocrystal Pharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 18.14 means the company can pay off $18.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 18.142. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 35.376. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ18.142TTM35.376-17.234
TTM35.376YOY22.127+13.249
TTM35.3765Y13.969+21.407
5Y13.96910Y7.628+6.341
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.1424.284+13.858
TTM35.3764.664+30.712
YOY22.1274.787+17.340
5Y13.9695.218+8.751
10Y7.6285.182+2.446

1.4. Solvency of Cocrystal Pharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cocrystal Pharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cocrystal Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that Cocrystal Pharma Inc assets are financed with 5.7% credit (debt) and the remaining percentage (100% - 5.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.057. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.022. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.057TTM0.022+0.035
TTM0.022YOY0.038-0.016
TTM0.0225Y0.063-0.041
5Y0.06310Y0.425-0.361
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0570.278-0.221
TTM0.0220.277-0.255
YOY0.0380.306-0.268
5Y0.0630.367-0.304
10Y0.4250.403+0.022
1.4.2. Debt to Equity Ratio

Measures if Cocrystal Pharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 6.1% means that company has $0.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.061. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.023. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.061TTM0.023+0.037
TTM0.023YOY0.040-0.017
TTM0.0235Y0.071-0.047
5Y0.07110Y1.878-1.807
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0610.315-0.254
TTM0.0230.317-0.294
YOY0.0400.319-0.279
5Y0.0710.403-0.332
10Y1.8780.462+1.416

2. Market Valuation of Cocrystal Pharma Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cocrystal Pharma Inc generates.

  • Above 15 is considered overpriced but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • A PE ratio of -0.14 means the investor is paying $-0.14 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cocrystal Pharma Inc:

  • The EOD is -0.911. Company is losing money. -2
  • The MRQ is -0.136. Company is losing money. -2
  • The TTM is -1.199. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.911MRQ-0.136-0.775
MRQ-0.136TTM-1.199+1.062
TTM-1.199YOY-34.280+33.081
TTM-1.1995Y-22.542+21.344
5Y-22.54210Y-15.947-6.595
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.911-8.986+8.075
MRQ-0.136-9.792+9.656
TTM-1.199-16.243+15.044
YOY-34.280-20.876-13.404
5Y-22.542-16.665-5.877
10Y-15.947-14.732-1.215
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Cocrystal Pharma Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.165. Very good. +2
  • The TTM is -2.384. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ0.165TTM-2.384+2.549
TTM-2.384YOY57.220-59.604
TTM-2.3845Y26.510-28.894
5Y26.51010Y13.300+13.210
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.165-0.032+0.197
TTM-2.3840.004-2.388
YOY57.2200.016+57.204
5Y26.5100.006+26.504
10Y13.3000.003+13.297

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cocrystal Pharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.07 means the investor is paying $0.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cocrystal Pharma Inc:

  • The EOD is 0.451. Very good. +2
  • The MRQ is 0.067. Very good. +2
  • The TTM is 0.075. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.451MRQ0.067+0.383
MRQ0.067TTM0.075-0.007
TTM0.075YOY1.436-1.361
TTM0.0755Y0.880-0.806
5Y0.88010Y0.237+0.644
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.4511.835-1.384
MRQ0.0672.006-1.939
TTM0.0752.774-2.699
YOY1.4363.453-2.017
5Y0.8802.713-1.833
10Y0.2372.402-2.165
2. Total Gains per Share

2.4. Latest News of Cocrystal Pharma Inc

Does Cocrystal Pharma Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Cocrystal Pharma Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-12-01
22:05
Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022Read
2022-11-17
14:00
Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza ARead
2022-11-14
14:00
Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development ProgramsRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cocrystal Pharma Inc.

3.1. Institutions holding Cocrystal Pharma Inc

Institutions are holding 21.344% of the shares of Cocrystal Pharma Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Sabby Management LLC6.04181.642458889272768904.9339
2022-06-30Vanguard Group Inc3.339603255085-17553-0.5364
2022-06-30Renaissance Technologies Corp1.74640.00081702238-2090-0.1226
2022-06-30Geode Capital Management, LLC0.83040.000180940388011.0993
2022-06-30State Street Corporation0.3009029329000
2022-06-30Parallel Advisors, LLC0.18750.003418270800
2022-06-30Verition Fund Managegment, LLC0.16420.001316000000
2022-06-30Northern Trust Corp0.1472014347400
2022-06-30Bank of America Corp0.1105010769500
2022-06-30Bank of New York Mellon Corp0.045704452300
2022-06-30Brighton Jones LLC0.02870.00062800000
2022-06-30Commonwealth Equity Services Inc0.027202654900
2022-06-30Tower Research Capital LLC0.02640.00032575417339206.0487
2022-06-30Western Wealth Management, LLC0.02340.00062281500
2022-06-30JANE STREET GROUP, LLC0.0152014845148450
2022-06-30TWO SIGMA SECURITIES, LLC0.01310.000212768127680
2022-06-30Goldman Sachs Group Inc0.0131012747127470
2022-06-30National Asset Management Inc0.01310.00031272600
2022-06-30Victory Capital Management Inc.0.0129012598-86-0.678
2022-06-30HRT FINANCIAL LLC0.01280.000112508125080
Total 13.10011.650112768653+336169+2.6%

3.2. Funds holding Cocrystal Pharma Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr0.19630.0001229630400
2022-09-30Fidelity® Extended Market Index0.04640.000654293200
2022-10-31Vanguard Total Stock Mkt Idx Inv2.3559019135980.0042
2022-09-30Fidelity® Total Market Index0.00870.000110230700
2022-09-30SSgA U.S. Extended Market Index Class I0.00660.0017760000
2022-09-30State St US Extended Mkt Indx NL Cl C0.00660.0017760000
2022-09-30Fidelity® Series Total Market Index0.00660.00017679200
2022-09-30NT Ext Equity Mkt Idx Fd - NL0.00630.00047418300
2022-10-31Vanguard Extended Market Index Investor0.86320.00027011430.0043
2022-09-30NT Ext Equity Mkt Idx Fd - L0.00550.00056420800
2022-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.00510.0005598187981.3521
2022-09-30Fidelity® NASDAQ Composite Index®0.00430.00025066700
2022-09-30Vanguard U.S. Eq Idx £ Acc0.00230.00012650600
2022-09-30SSgA U.S. Total Market Index Strategy0.00210.000224023760.3174
2022-09-30Spartan Total Market Index Pool E0.00202297400
2022-09-30Spartan Extended Market Index Pool E0.00120.00051373100
2022-02-28The Vanguard Total Stock Market Index0.00090.00011056300
2022-09-30State St US Ttl Mkt Indx NL Cl C0.00080.0001970000
2022-09-30USAA Extended Market Index0.00080.00049074-3524-27.9727
2022-10-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.09330.0001757610.0132
Total 3.61490.00623808031-2638-0.1%

3.3. Insider Transactions

Insiders are holding 13.231% of the shares of Cocrystal Pharma Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-08-20Richard C. Pfenniger, Jr.BUY400001.0340000
2021-05-04Raymond F SchinaziSELL5750002.957674960
2019-10-25Raymond F SchinaziBUY169351.11 
2016-12-23Sam LeeSELL22000000.4413087847
2016-09-01Gary WilcoxBUY100000.41
2016-09-01Raymond F SchinaziBUY48780500.41275520853
2016-03-15Jane Ph D HsiaoBUY12352940.513435294
2016-03-15Jeffrey A MecklerBUY2941180.51657161
2015-12-23Jeffrey A MecklerBUY1000000.58363043
2015-04-21Raymond F SchinaziBUY34648550.92
2015-03-25Gary WilcoxBUY543480.92
2015-03-25Jeffrey A MecklerBUY1630430.92
2014-12-15Phillip Md Et Al FrostBUY250000.43
2014-08-12Phillip Md Et Al FrostBUY1112000.29

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cocrystal Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.9781.277-333%0.066-4635%0.093-3308%0.164-1914%
Book Value Growth---0.490-0.159-68%0.171-387%-0.098-80%1.294-138%
Book Value Per Share--6.0818.751-31%0.872+597%3.511+73%3.363+81%
Book Value Per Share Growth---0.4900.075-754%0.057-952%-0.145-70%1.242-139%
Current Ratio--18.34235.786-49%22.265-18%14.076+30%7.707+138%
Debt To Asset Ratio--0.0570.022+157%0.038+49%0.063-10%0.425-87%
Debt To Equity Ratio--0.0610.023+160%0.040+52%0.071-14%1.878-97%
Dividend Per Share----0%-0%-0%-0%
Eps---3.007-1.116-63%-0.039-99%-0.371-88%-0.423-86%
Eps Growth---0.828-0.448-46%0.196-522%1.470-156%4.687-118%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.042-4%
Net Profit Margin----0.1700%-3.4390%-7.9490%-45.4270%
Operating Margin----0.1700%-3.4370%-8.0650%-52.4900%
Operating Ratio---0.171-100%3.946-100%2.903-100%73.968-100%
Pb Ratio0.451+85%0.0670.075-10%1.436-95%0.880-92%0.237-72%
Pe Ratio-0.911-568%-0.136-1.199+779%-34.280+25046%-22.542+16436%-15.947+11598%
Peg Ratio--0.165-2.384+1548%57.220-100%26.510-99%13.300-99%
Price Per Share2.740+85%0.4100.665-38%1.232-67%1.681-76%1.174-65%
Price To Total Gains Ratio-0.920-568%-0.138-0.628+356%9.222-101%-6.552+4659%-0.308+124%
Profit Growth---82.77426665.338-100%8.980-1022%5560.771-101%3004.544-103%
Quick Ratio--18.14235.376-49%22.127-18%13.969+30%7.628+138%
Return On Assets---0.466-0.142-69%-0.043-91%-0.195-58%-0.206-56%
Return On Equity---0.495-0.150-70%-0.045-91%-0.209-58%-0.373-25%
Total Gains Per Share---2.9781.277-333%0.066-4635%0.093-3308%0.164-1914%
Total Gains Per Share Growth---0.772-6.214+705%0.038-2107%-1.611+109%-0.988+28%
Usd Book Value--49393000.00071076750.000-31%59872000.000-18%71850450.000-31%74512478.000-34%
Usd Book Value Change Per Share---2.9781.277-333%0.066-4635%0.093-3308%0.164-1914%
Usd Book Value Per Share--6.0818.751-31%0.872+597%3.511+73%3.363+81%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---3.007-1.116-63%-0.039-99%-0.371-88%-0.423-86%
Usd Price Per Share2.740+85%0.4100.665-38%1.232-67%1.681-76%1.174-65%
Usd Profit---24428000.000-8145171.250-67%-2680500.000-89%-9516334.250-61%-8605658.725-65%
Usd Revenue---1356.750-100%377250.000-100%454671.350-100%396536.825-100%
Usd Total Gains Per Share---2.9781.277-333%0.066-4635%0.093-3308%0.164-1914%
 EOD+2 -3MRQTTM+5 -24YOY+6 -235Y+12 -1710Y+12 -18

4.2. Fundamental Score

Let's check the fundamental score of Cocrystal Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.911
Price to Book Ratio (EOD)Between0-10.451
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than118.142
Current Ratio (MRQ)Greater than118.342
Debt to Asset Ratio (MRQ)Less than10.057
Debt to Equity Ratio (MRQ)Less than10.061
Return on Equity (MRQ)Greater than0.15-0.495
Return on Assets (MRQ)Greater than0.05-0.466
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Cocrystal Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.720
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets52,383
Total Liabilities2,990
Total Stockholder Equity49,393
 As reported
Total Liabilities 2,990
Total Stockholder Equity+ 49,393
Total Assets = 52,383

Assets

Total Assets52,383
Total Current Assets51,596
Long-term Assets51,596
Total Current Assets
Cash And Cash Equivalents 51,033
Other Current Assets 563
Total Current Assets  (as reported)51,596
Total Current Assets  (calculated)51,596
+/-0
Long-term Assets
Property Plant Equipment 741
Other Assets 46
Long-term Assets  (as reported)787
Long-term Assets  (calculated)787
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,813
Long-term Liabilities177
Total Stockholder Equity49,393
Total Current Liabilities
Short-term Debt 242
Accounts payable 971
Other Current Liabilities 1,600
Total Current Liabilities  (as reported)2,813
Total Current Liabilities  (calculated)2,813
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt177
Long-term Liabilities  (as reported)177
Long-term Liabilities  (calculated)177
+/-0
Total Stockholder Equity
Common Stock98
Retained Earnings -287,729
Other Stockholders Equity 337,024
Total Stockholder Equity (as reported)49,393
Total Stockholder Equity (calculated)49,393
+/-0
Other
Capital Stock98
Cash and Short Term Investments 51,033
Common Stock Shares Outstanding 8,122
Liabilities and Stockholders Equity 52,383
Net Debt -50,614
Net Invested Capital 49,393
Net Tangible Assets 49,393
Net Working Capital 48,783
Short Long Term Debt Total 419



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-30
> Total Assets 
0
171
162
148
142
137
125
121
117
113
113
94
91
89
2,337
11,120
10,706
7,547
7,547
9,071
8,260
7,240
7,240
7,701
7,597
6,456
10,481
12,967
11,635
259,283
268,603
269,129
266,160
224,230
225,168
220,148
220,901
124,883
122,518
124,340
122,253
121,426
120,721
126,325
124,171
68,562
68,562
74,907
73,437
28,531
42,841
40,478
53,216
54,242
53,851
87,417
82,598
79,392
75,372
52,383
52,38375,37279,39282,59887,41753,85154,24253,21640,47842,84128,53173,43774,90768,56268,562124,171126,325120,721121,426122,253124,340122,518124,883220,901220,148225,168224,230266,160269,129268,603259,28311,63512,96710,4816,4567,5977,7017,2407,2408,2609,0717,5477,54710,70611,1202,3378991941131131171211251371421481621710
   > Total Current Assets 
0
110
100
85
80
75
63
54
50
46
46
28
25
23
2,122
6,444
6,056
2,904
2,904
4,369
3,644
2,670
2,670
3,235
2,826
6,456
10,037
10,097
5,803
6,376
15,754
16,329
13,225
9,919
10,916
5,936
6,755
5,472
3,100
4,941
2,879
2,176
1,481
7,099
4,991
2,943
2,943
8,533
7,013
8,281
22,582
20,102
32,899
34,015
33,691
67,337
62,441
59,323
55,399
51,596
51,59655,39959,32362,44167,33733,69134,01532,89920,10222,5828,2817,0138,5332,9432,9434,9917,0991,4812,1762,8794,9413,1005,4726,7555,93610,9169,91913,22516,32915,7546,3765,80310,09710,0376,4562,8263,2352,6702,6703,6444,3692,9042,9046,0566,4442,12223252846465054637580851001100
       Cash And Cash Equivalents 
0
110
95
85
79
75
62
49
46
43
43
27
25
23
2,122
1,840
782
416
416
174
83
62
62
354
530
589
2,599
4,074
3,006
3,970
14,257
15,781
12,413
9,276
10,242
5,022
5,906
3,640
1,555
3,451
1,345
748
1,249
6,841
4,684
2,723
2,723
7,474
5,994
7,418
21,686
19,315
31,781
33,010
33,278
67,062
61,644
58,705
54,789
51,033
51,03354,78958,70561,64467,06233,27833,01031,78119,31521,6867,4185,9947,4742,7232,7234,6846,8411,2497481,3453,4511,5553,6405,9065,02210,2429,27612,41315,78114,2573,9703,0064,0742,5995895303546262831744164167821,8402,1222325274343464962757985951100
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,285
5,719
2,500
1,975
993
0
0
0
0
0
0
0
0
0
0
29
29
29
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002929292900000000009931,9752,5005,7197,28500000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,671
1,826
523
523
1,261
920
835
835
1,153
362
0
0
148
181
287
312
184
180
202
188
226
224
1,315
1,294
1,294
1,294
1,295
1,295
0
0
0
1,078
914
768
644
644
592
581
556
556
0
0
0
0
0
000005565565815926446447689141,0780001,2951,2951,2941,2941,2941,315224226188202180184312287181148003621,1538358359201,2615235231,8261,671000000000000000
       Other Current Assets 
0
0
5
0
0
1
1
5
4
0
3
1
0
0
0
94
60
0
145
562
490
0
122
203
208
5,867
153
156
116
144
192
364
632
441
486
688
625
517
251
196
240
133
232
258
307
220
220
145
251
219
252
195
537
449
413
275
797
618
610
563
5636106187972754134495371952522192511452202203072582321332401962515176256884864416323641921441161561535,867208203122049056214506094000130451100500
   > Long-term Assets 
0
61
62
62
62
62
62
67
67
0
67
67
67
67
214
4,677
4,650
0
4,642
4,703
4,616
0
4,569
4,466
4,771
0
444
2,870
5,832
252,907
252,849
252,800
252,935
214,311
214,252
214,212
214,146
119,411
119,418
119,399
119,374
119,250
119,240
119,226
119,180
65,619
65,619
66,374
66,424
20,250
20,259
20,376
20,317
20,227
20,160
20,080
20,157
20,069
19,973
787
78719,97320,06920,15720,08020,16020,22720,31720,37620,25920,25066,42466,37465,61965,619119,180119,226119,240119,250119,374119,399119,418119,411214,146214,212214,252214,311252,935252,800252,849252,9075,8322,87044404,7714,4664,56904,6164,7034,64204,6504,67721467676767067676262626262610
       Property Plant Equipment 
0
0
1
1
1
1
1
6
6
6
6
5
5
5
5
3,139
3,187
3,342
3,342
3,410
3,344
3,334
3,334
3,263
3,133
0
412
361
314
284
245
215
369
430
392
357
320
280
287
268
243
119
109
95
31
384
384
1,129
1,179
1,108
1,128
1,249
1,179
1,089
1,022
942
1,019
931
835
741
7418359311,0199421,0221,0891,1791,2491,1281,1081,1791,129384384319510911924326828728032035739243036921524528431436141203,1333,2633,3343,3343,3443,4103,3423,3423,1873,139555566661111100
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,299
1,354
1,027
1,027
1,027
1,027
1,027
1,027
1,027
1,027
0
0
0
0
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
0
019,09219,09219,09219,09219,09219,09219,09219,09219,09219,09265,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19500001,0271,0271,0271,0271,0271,0271,0271,0271,3541,299000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,496
2,431
2,412
2,393
2,374
2,354
2,333
2,303
2,276
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000002,2762,3032,3332,3542,3742,3932,4122,4315,4960000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
247
247
219
205
191
191
163
148
0
0
0
0
184,966
184,966
184,966
184,966
146,301
146,301
146,301
146,301
53,905
53,905
53,905
53,905
53,905
53,905
53,905
53,905
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000053,90553,90553,90553,90553,90553,90553,90553,905146,301146,301146,301146,301184,966184,966184,966184,966000014816319119120521924724700000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
2,509
5,518
252,623
252,604
252,585
252,566
213,881
213,860
213,855
213,826
119,131
119,131
119,131
119,131
119,131
53,936
53,936
53,954
40
40
50
50
50
39
35
590
544
46
46
46
46
46
46
4646464646465445903539505050404053,95453,93653,936119,131119,131119,131119,131119,131213,826213,855213,860213,881252,566252,585252,604252,6235,5182,5093200000000000000000000000000
> Total Liabilities 
0
24
36
36
38
42
46
50
52
58
58
63
76
82
2,334
10,754
10,883
10,316
10,316
13,003
8,335
10,820
10,820
13,010
18,051
12,482
12,555
6,911
7,657
252,632
79,905
72,606
69,407
56,636
55,825
53,315
53,079
22,564
22,535
22,304
22,255
16,026
16,585
13,679
13,270
1,674
1,674
2,489
2,692
2,823
2,410
3,423
3,039
1,737
1,793
2,669
358
298
1,792
2,990
2,9901,7922983582,6691,7931,7373,0393,4232,4102,8232,6922,4891,6741,67413,27013,67916,58516,02622,25522,30422,53522,56453,07953,31555,82556,63669,40772,60679,905252,6327,6576,91112,55512,48218,05113,01010,82010,8208,33513,00310,31610,31610,88310,7542,334827663585852504642383636240
   > Total Current Liabilities 
0
24
36
36
38
42
46
50
52
58
58
63
76
82
2,334
7,543
7,796
7,278
7,278
10,049
5,421
7,926
7,926
10,108
15,287
12,482
12,555
6,911
7,657
9,157
14,648
7,349
4,151
6,700
5,891
3,383
3,150
2,039
2,026
1,800
1,756
1,406
1,358
1,053
1,137
1,557
1,557
1,854
2,105
2,286
1,925
2,943
2,614
1,358
1,457
2,379
1,228
1,545
1,558
2,813
2,8131,5581,5451,2282,3791,4571,3582,6142,9431,9252,2862,1051,8541,5571,5571,1371,0531,3581,4061,7561,8002,0262,0393,1503,3835,8916,7004,1517,34914,6489,1577,6576,91112,55512,48215,28710,1087,9267,9265,42110,0497,2787,2787,7967,5432,334827663585852504642383636240
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,741
4,134
261
3,410
2,576
1,422
1,654
2,754
3,493
2,421
8,489
12,089
6,450
7,242
8,464
13,456
6,130
3,096
4,115
2,807
1,869
1,907
1,476
905
707
855
569
548
288
159
477
214
370
325
280
232
226
228
217
203
190
466
236
243
242
2422432364661902032172282262322803253702144771592885485698557079051,4761,9071,8692,8074,1153,0966,13013,4568,4647,2426,45012,0898,4892,4213,4932,7541,6541,4222,5763,4102614,1345,741000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,464
0
0
0
4,115
0
1,869
1,907
1,476
905
707
855
1,007
2,039
0
0
0
161
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001610002,0391,0078557079051,4761,9071,86904,1150008,46400000000000000000000000000000
       Accounts payable 
0
24
36
36
38
0
0
0
0
0
0
0
0
0
82
1,435
2,725
0
1,617
1,608
1,019
0
736
1,462
209
77
289
180
125
299
737
838
724
2,585
3,084
1,514
1,243
563
1,121
1,093
901
837
810
765
978
1,077
616
1,071
1,092
1,511
922
832
1,485
657
748
939
961
1,297
858
971
9718581,2979619397486571,4858329221,5111,0921,0716161,0779787658108379011,0931,1215631,2431,5143,0842,585724838737299125180289772091,46273601,0191,6081,61702,7251,43582000000000383636240
       Other Current Liabilities 
0
0
0
0
0
42
46
50
52
0
58
63
76
82
2,252
366
936
0
2,251
5,865
2,980
0
4,436
5,153
12,657
12,482
12,266
6,731
7,532
8,858
13,911
6,511
3,427
4,115
2,807
1,869
1,907
1,476
905
707
855
569
548
288
159
3
727
413
688
495
771
1,885
901
484
506
1,250
762
1,309
457
1,600
1,6004571,3097621,2505064849011,88577149568841372731592885485698557079051,4761,9071,8692,8074,1153,4276,51113,9118,8587,5326,73112,26612,48212,6575,1534,43602,9805,8652,25109363662,2528276635805250464200000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,211
3,087
0
3,038
2,954
2,913
0
2,895
2,901
2,764
0
0
0
0
243,475
65,257
65,257
65,256
49,936
49,934
49,932
49,929
20,525
20,509
20,504
20,499
14,620
15,227
12,626
12,133
117
117
635
587
537
485
480
425
379
336
290
-870
-1,247
234
177
177234-1,247-87029033637942548048553758763511711712,13312,62615,22714,62020,49920,50420,50920,52549,92949,93249,93449,93665,25665,25765,257243,47500002,7642,9012,89502,9132,9543,03803,0873,211000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,211
3,087
0
0
0
0
0
0
0
0
0
0
0
0
65,257
0
0
0
49,936
0
0
0
0
0
0
0
1,007
2,039
0
0
117
61
21
18
14
10
0
0
0
0
0
0
0
0
0
0000000001014182161117002,0391,007000000049,93600065,2570000000000003,0873,211000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
62
62
62
61
61
59
57
54
63
47
42
37
31
13,188
12,626
12,133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000012,13312,62613,1883137424763545759616162626200000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
184,966
65,257
65,257
65,256
146,301
49,934
49,932
49,929
20,525
20,509
20,504
20,499
13,613
13,188
12,626
12,133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000012,13312,62613,18813,61320,49920,50420,50920,52549,92949,93249,934146,30165,25665,25765,257184,96600000000000000000000000000000
> Total Stockholder Equity
0
148
127
113
105
97
80
73
67
0
57
34
19
10
6
366
-178
0
-2,769
-3,932
-75
0
-3,580
-5,309
-10,455
-6,026
-2,074
6,056
3,978
6,651
188,698
196,523
196,753
167,594
169,343
166,833
167,822
102,319
99,983
102,036
99,998
105,400
104,136
112,646
110,901
66,888
66,888
72,418
70,745
25,708
40,431
37,055
50,177
52,505
52,058
84,748
81,012
77,549
73,580
49,393
49,39373,58077,54981,01284,74852,05852,50550,17737,05540,43125,70870,74572,41866,88866,888110,901112,646104,136105,40099,998102,03699,983102,319167,822166,833169,343167,594196,753196,523188,6986,6513,9786,056-2,074-6,026-10,455-5,309-3,5800-75-3,932-2,7690-1783666101934570677380971051131271480
   Common Stock
0
4
4
4
4
4
4
4
4
0
4
4
4
4
38
67
68
0
55
62
63
0
63
69
70
114
122
122
123
123
687
694
694
694
704
704
714
714
714
727
728
24
24
30
30
30
30
32
32
36
53
53
69
71
72
98
98
98
98
98
989898989872716953533632323030303024247287277147147147047046946946946871231231221221147069630636255068673844440444444440
   Retained Earnings Total Equity0000-251,467-247,646-244,908-243,415-240,745-237,250-235,260-187,415-185,635-184,120-187,091-142,805-140,940-139,596-138,043-143,240-140,981-139,978-137,430-71,676-69,795-66,568-62,556-32,107-31,599-28,976-12,434-10,527-7,978-12,707-33,75000000000-4,373-2,033000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
-1
-1
-1
-1
-1
-1
0
-4,224
-4,307
-4,558
-4,558
-4,765
-4,871
-4,929
-4,929
0
-5,280
0
-1,451
1,827
2,235
236
-744
0
0
-1,153
-1,153
0
0
-1,354
-1,354
0
0
-1,358
-1,358
0
0
-983
-983
-1,028
-1,053
-1,081
-1,111
-1,056
-1,102
0
-1,159
0
0
0
0
0
00000-1,1590-1,102-1,056-1,111-1,081-1,053-1,028-983-98300-1,358-1,35800-1,354-1,35400-1,153-1,15300-7442362,2351,827-1,4510-5,2800-4,929-4,929-4,871-4,765-4,558-4,558-4,307-4,2240-1-1-1-1-1-100000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,332
4,128
0
0
0
0
0
0
0
0
27,610
11,961
12,084
12,146
18,725
217,731
227,428
228,166
229,456
235,207
235,924
238,784
239,035
239,247
242,290
242,510
243,419
243,708
253,556
253,676
253,949
257,908
258,021
258,128
260,932
277,628
277,747
293,523
297,342
299,632
336,117
0
0
0
0
0000336,117299,632297,342293,523277,747277,628260,932258,128258,021257,908253,949253,676253,556243,708243,419242,510242,290239,247239,035238,784235,924235,207229,456228,166227,428217,73118,72512,14612,08411,96127,610000000004,1282,332000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
206
206
207
207
208
208
209
209
0
210
211
211
212
177
6,556
8,435
0
7,897
18,183
15,355
0
15,414
10,972
16,414
27,610
11,962
12,085
12,147
18,726
217,731
227,428
228,166
230,609
235,207
235,924
238,784
240,389
239,247
242,290
242,510
244,777
243,708
253,556
253,676
0
254,932
259,049
259,181
262,013
278,739
278,803
294,625
297,342
300,791
336,117
336,322
336,544
336,783
337,024
337,024336,783336,544336,322336,117300,791297,342294,625278,803278,739262,013259,181259,049254,9320253,676253,556243,708244,777242,510242,290239,247240,389238,784235,924235,207230,609228,166227,428217,73118,72612,14712,08511,96227,61016,41410,97215,414015,35518,1837,89708,4356,55617721221121121002092092082082072072062060



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.